Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PerkinElmer reported financial results for the fourth quarter and full year ended December 31, 2017.
read more
Thursday, August 03, 2023
GENIXUS announced the accelerated development and launch* of the latest product within their KinetiX syringe platform: Rocuronium Bromide Injection.
read more
Friday, September 15, 2023
Charles River Laboratories International, Inc. and Related Sciences, a data science-driven drug discovery firm, announced a multi-program collaboration agreement to apply Logica™ across several previously undrugged targets in the RS portfolio.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Phillips-Medisize announced an agreement with a leading biotechnology company to manufacture a wearable, electronic-enabled combination product.
read more
Elevation Oncology and US Oncology announced a collaboration to utilize the US Oncology Research STAR program for patient enrollment in the registration-enabling Phase 2 CRESTONE study.
read more
BioWa, Inc. and Lonza today announced that they have entered into research agreements with Pfizer Inc. allowing the use of the POTELLIGENT® CHOK1SV Cell Line in the research and development of multiple proprietary antibodies in Pfizer’s pipeline.
read more
Trovagene has entered into an agreement with AstraZeneca to provide Trovera® urine ctDNA biomarker test and services.
read more
Thursday, January 23, 2020
Catalent supports the news that DiaMedica received FDA approval to commence Phase 2 clinical trials of DM199 for chronic kidney disease.
read more
I-MED Pharma is collaborating with KMG International Limited to manufacture and supply PPE and COVID-19 diagnostic tests.
read more
Wednesday, August 02, 2023
Sygnature Discovery announced the acquisition of Canada-based NuChem Sciences. This acquisition cements Sygnature as one of the world’s largest players in integrated drug discovery phase solutions and advances their vision to become the global market...
read more
Tuesday, December 29, 2015
Pfizer Inc. today announced that it has completed its acquisition of Hospira, Inc.
read more
Thursday, November 10, 2016
Cell Culture Company (C3), a biopharmaceutical developer and manufacturer, has entered into an agreement with a China-based joint venture to produce a clinical-grade antibody-based therapeutic vaccine targeting pancreatic cancer.
read more
Wednesday, April 13, 2022
Cambrex announced the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility.
read more
Tuesday, February 20, 2024
National Resilience, Inc. (Resilience) announced the expansion of the company’s clinical and commercial drug product manufacturing capabilities across its network. By scaling this capacity, Resilience aims to provide over 200 million units to its ...
read more